List of Biostorage/Biorepositories Companies in Pennsylvania - 4

Animal Biotech Industries, Inc. is a private corporation that was established in 1990 to support the biomedical research community by supplying them with high quality post mortem tissues, organs and glands. To this end, ABI was conceived and is currently operated by scientific professionals who have dedicated themselves to producing superior animals and tissues as well as superior service.

CellPort Software's secure, compliant, SaaS-based application suite defines and manages all assay workflows, activities, equipment, materials, personnel, data/calculations and projects used by CROs, CMOs, research institutions, bio-pharma companies and regulatory authorities in assay development and biomanufacturing at all stages of development (R&D, GLP, GMP). The CellPort Cell Culture Suite combines the end-to-end laboratory inventory and process management of a Laboratory Information Management System (LIMS) with the highly repeatable QC and manufacturing focus of an Laboratory Execution System (LES).

Gnosko provides the only real-time automation solution in the Life Sciences Industry. Through close collaboration with our clients, we pinpointed a crucial challenge: even though they worked in state-of-the-art labs with advanced automated tools, many struggled with outdated inventory management practices. Motivated by a dedication to help others, we embraced an opportunity. Our vision extended beyond mere distribution – we evolved into partners with our clients, often being called “an extension of their team”. By grasping our customers’ business, applications, processes, and obstacles, we provide comprehensive solutions that empower advancement at an accelerated pace. We blend technology and a customer-focused strategy with our top-tier supplier network to simplify laboratory inventory management.

Our mission at Predictive Oncology is to change the landscape of oncology drug discovery and enable the development of more effective therapies in the treatment of cancer. By harnessing the power of machine learning, scientific rigor and biologics, we can improve the probability of success and advance drug compounds with a higher degree of confidence. We invite you to follow us to stay up-to-date about our latest developments.